发布求助
文献互助 智能选刊 最新文献

Breathe最新文献

筛选
英文 中文
Interventional bronchoscopy in lung cancer treatment. 介入性支气管镜在肺癌治疗中的应用。
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0201-2023
Ales Rozman, Elzbieta Magdalena Grabczak, Vineeth George, Mateja Marc Malovrh, Helder Novais Bastos, Anna Trojnar, Simon Graffen, Eric Daniel Tenda, Georgia Hardavella
{"title":"Interventional bronchoscopy in lung cancer treatment.","authors":"Ales Rozman, Elzbieta Magdalena Grabczak, Vineeth George, Mateja Marc Malovrh, Helder Novais Bastos, Anna Trojnar, Simon Graffen, Eric Daniel Tenda, Georgia Hardavella","doi":"10.1183/20734735.0201-2023","DOIUrl":"10.1183/20734735.0201-2023","url":null,"abstract":"<p><p>Interventional bronchoscopy has seen significant advancements in recent decades, particularly in the context of lung cancer. This method has expanded not only diagnostic capabilities but also therapeutic options. In this article, we will outline various therapeutic approaches employed through either a rigid or flexible bronchoscope in multimodal lung cancer treatment. A pivotal focus lies in addressing central airway obstruction resulting from cancer. We will delve into the treatment of initial malignant changes in central airways and explore the rapidly evolving domain of early peripheral malignant lesions, increasingly discovered incidentally or through lung cancer screening programmes. A successful interventional bronchoscopic procedure not only alleviates severe symptoms but also enhances the patient's functional status, paving the way for subsequent multimodal treatments and thereby extending the possibilities for survival. Interventional bronchoscopy proves effective in treating initial cancerous changes in patients unsuitable for surgical or other aggressive treatments due to accompanying diseases. The key advantage of interventional bronchoscopy lies in its minimal invasiveness, effectiveness and favourable safety profile.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer screening: where do we stand? 肺癌筛查：现状如何？
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0190-2023
Georgia Hardavella, Armin Frille, Katherina Bernadette Sreter, Florence Atrafi, Uraujh Yousaf-Khan, Ferhat Beyaz, Fotis Kyriakou, Elena Bellou, Monica L Mullin, Sam M Janes
{"title":"Lung cancer screening: where do we stand?","authors":"Georgia Hardavella, Armin Frille, Katherina Bernadette Sreter, Florence Atrafi, Uraujh Yousaf-Khan, Ferhat Beyaz, Fotis Kyriakou, Elena Bellou, Monica L Mullin, Sam M Janes","doi":"10.1183/20734735.0190-2023","DOIUrl":"10.1183/20734735.0190-2023","url":null,"abstract":"<p><p>Lung cancer screening (LCS) programmes have emerged over recent years around the world. LCS programmes present differences in delivery, inclusion criteria and resource allocation. On a national scale, only a few LCS programmes have been fully established, but more are anticipated to follow. Evidence has shown that, in combination with a low-dose chest computed tomography scan, smoking cessation should be offered as part of a LCS programme for improved patient outcomes. Promising tools in LCS include further refined risk prediction models, the use of biomarkers, artificial intelligence and radiomics. However, these tools require further study and clinical validation is required prior to routine implementation.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A scoping review of lung cancer surgery with curative intent: workup, fitness assessment, clinical outcomes. 以治愈为目的的肺癌手术范围综述：准备工作、体能评估、临床结果。
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0046-2024
Georgia Hardavella, Federica Carlea, Ioannis Karampinis, Alexandro Patirelis, Kalliopi Athanasiadi, Dimitrios Lioumpas, Joana Rei, Lucas Hoyos, Georgios Benakis, Edward Caruana, Eugenio Pompeo, Stefano Elia
{"title":"A scoping review of lung cancer surgery with curative intent: workup, fitness assessment, clinical outcomes.","authors":"Georgia Hardavella, Federica Carlea, Ioannis Karampinis, Alexandro Patirelis, Kalliopi Athanasiadi, Dimitrios Lioumpas, Joana Rei, Lucas Hoyos, Georgios Benakis, Edward Caruana, Eugenio Pompeo, Stefano Elia","doi":"10.1183/20734735.0046-2024","DOIUrl":"10.1183/20734735.0046-2024","url":null,"abstract":"<p><p>Lung cancer surgery with curative intent has significantly developed over recent years, mainly focusing on minimally invasive approaches that do not compromise medical efficiency and ensure a decreased burden on the patient. It is directly linked with an efficient multidisciplinary team that will perform appropriate pre-operative assessment. Caution is required in complex patients with several comorbidities to ensure a meaningful and informed thoracic surgery referral leading to optimal patient outcomes.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant immunotherapy and targeted therapy in early and locally advanced resectable lung cancer: expanding treatment tentacles? 早期和局部晚期可切除肺癌的辅助免疫疗法和靶向疗法：扩大治疗触角？
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0035-2024
Evaggelos Fergadis, Amadea Heitmann, Theodore Tsaras, Georgia Hardavella
{"title":"Adjuvant immunotherapy and targeted therapy in early and locally advanced resectable lung cancer: expanding treatment tentacles?","authors":"Evaggelos Fergadis, Amadea Heitmann, Theodore Tsaras, Georgia Hardavella","doi":"10.1183/20734735.0035-2024","DOIUrl":"10.1183/20734735.0035-2024","url":null,"abstract":"<p><p>Adjuvant platinum-based chemotherapy has been the main treatment following surgical resection with curative intent in early and locally advanced nonsmall cell lung cancer (NSCLC) albeit with a 5% improvement in 5-year survival rates. Recent advances in biomarkers pave the way for targeted treatments and immunotherapy in a broader spectrum of patients with subsequently improved clinical outcomes. Targeted treatments and immunotherapy have established their place in the adjuvant setting of resected NSCLC.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer: an update on the multidisciplinary approach from screening to palliative care. 肺癌：从筛查到姑息治疗的多学科方法的最新进展。
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0117-2024
Georgia Hardavella, Joanna Chorostowska-Wynimko, Torsten Gerriet Blum
{"title":"Lung cancer: an update on the multidisciplinary approach from screening to palliative care.","authors":"Georgia Hardavella, Joanna Chorostowska-Wynimko, Torsten Gerriet Blum","doi":"10.1183/20734735.0117-2024","DOIUrl":"10.1183/20734735.0117-2024","url":null,"abstract":"<p><p><b>This issue of <i>Breathe</i> aims to provide a succinct overview of the current state of play in various aspects in thoracic oncology</b> https://bit.ly/3XQexmp.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two women with unexplained dyspnoea: removing the blame game from the lungs. 两名不明原因呼吸困难的妇女：从肺部消除指责游戏。
IF 2.3
Breathe Pub Date : 2024-08-27 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0029-2024
Eirini Vasarmidi, Irini Lambiri, Eirini Foteinaki, Vaia Stamatopoulou, Ioanna Mitrouska, Georgios Pitsidianakis, Alexandros Patrianakos, Anthoula Plevritaki, Stylianos Michelakis, Vasilis Amargianitakis, Georgios Prinianakis, Sophia Schiza, Nikolaos Tzanakis
{"title":"Two women with unexplained dyspnoea: removing the blame game from the lungs.","authors":"Eirini Vasarmidi, Irini Lambiri, Eirini Foteinaki, Vaia Stamatopoulou, Ioanna Mitrouska, Georgios Pitsidianakis, Alexandros Patrianakos, Anthoula Plevritaki, Stylianos Michelakis, Vasilis Amargianitakis, Georgios Prinianakis, Sophia Schiza, Nikolaos Tzanakis","doi":"10.1183/20734735.0029-2024","DOIUrl":"https://doi.org/10.1183/20734735.0029-2024","url":null,"abstract":"<p><p><b>Hypoxaemia due to right-to-left atrial shunt with normal pressures in the right heart cavities represents an underdiagnosed condition. A systematic approach to hypoxaemic respiratory failure based on pathophysiology can lead to an accurate diagnosis.</b> https://bit.ly/4bTP8fJ.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11356787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of radiological imaging in the management of severe and difficult-to-treat asthma. 放射成像在严重和难治性哮喘治疗中的作用。
IF 2.3
Breathe Pub Date : 2024-07-16 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0033-2024
Joshua Aigbirior, Amer Almaghrabi, Monder Lafi, Adel H Mansur
{"title":"The role of radiological imaging in the management of severe and difficult-to-treat asthma.","authors":"Joshua Aigbirior, Amer Almaghrabi, Monder Lafi, Adel H Mansur","doi":"10.1183/20734735.0033-2024","DOIUrl":"10.1183/20734735.0033-2024","url":null,"abstract":"<p><p>Radiological imaging has proven to be a useful tool in the assessment of asthma, its comorbidities and potential complications. Characteristic chest radiograph and computed tomography scan findings can be seen in asthma and in other conditions that can coexist with or be misdiagnosed as asthma, including chronic rhinosinusitis, inducible laryngeal obstruction, excessive dynamic airway collapse, tracheobronchomalacia, concomitant COPD, bronchiectasis, allergic bronchopulmonary aspergillosis, eosinophilic granulomatosis with polyangiitis, and eosinophilic pneumonia. The identification of the characteristic radiological findings of these conditions is often essential in making the correct diagnosis and provision of appropriate management and treatment. Furthermore, radiological imaging modalities can be used to monitor response to therapy.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: "Rolling out new anti-tuberculosis drugs without diagnostic capacity". T. Ness, L.H. Van, I. Petermane, R. Duarte, C. Lange, D. Menzies and D.M. Cirillo on behalf of the UNITE4TB Consortium. Breathe 2023; 19: 230084. 勘误："在没有诊断能力的情况下推广抗结核新药"。T. Ness、L.H. Van、I. Petermane、R. Duarte、C. Lange、D. Menzies 和 D.M. Cirillo 代表 UNITE4TB 联盟。呼吸 2023; 19: 230084.
IF 2.3
Breathe Pub Date : 2024-07-16 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.5084-2023
{"title":"Erratum: \"Rolling out new anti-tuberculosis drugs without diagnostic capacity\". T. Ness, L.H. Van, I. Petermane, R. Duarte, C. Lange, D. Menzies and D.M. Cirillo on behalf of the UNITE4TB Consortium. <i>Breathe</i> 2023; 19: 230084.","authors":"","doi":"10.1183/20734735.5084-2023","DOIUrl":"https://doi.org/10.1183/20734735.5084-2023","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1183/20734735.0084-2023.].</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: "Treatment-shortening regimens for tuberculosis: updates and future priorities". F. Saluzzo, V.A. Adepoju, R. Duarte, C. Lange and P.P.J. Phillips on behalf of the UNITE4TB Consortium12. Breathe 2023; 19: 230028. 勘误："结核病缩短疗程疗法：最新情况和未来优先事项"。F. Saluzzo、V.A. Adepoju、R. Duarte、C. Lange 和 P.P.J. Phillips 代表 UNITE4TB 联合会12。呼吸 2023；19：230028。
IF 2.3
Breathe Pub Date : 2024-07-16 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.5028-2023
{"title":"Erratum: \"Treatment-shortening regimens for tuberculosis: updates and future priorities\". F. Saluzzo, V.A. Adepoju, R. Duarte, C. Lange and P.P.J. Phillips on behalf of the UNITE4TB Consortium12. <i>Breathe</i> 2023; 19: 230028.","authors":"","doi":"10.1183/20734735.5028-2023","DOIUrl":"https://doi.org/10.1183/20734735.5028-2023","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1183/20734735.0028-2023.].</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling the diagnostic pathology and molecular biomarkers in lung cancer. 揭示肺癌的病理诊断和分子生物标记物。
IF 2.3
Breathe Pub Date : 2024-07-16 eCollection Date: 2024-06-01 DOI: 10.1183/20734735.0192-2023
Andriani Charpidou, Georgia Hardavella, Efimia Boutsikou, Emmanouil Panagiotou, Gökçen Ömeroğlu Simsek, Koen Verbeke, Daniela Xhemalaj, Joanna Domagała-Kulawik
{"title":"Unravelling the diagnostic pathology and molecular biomarkers in lung cancer.","authors":"Andriani Charpidou, Georgia Hardavella, Efimia Boutsikou, Emmanouil Panagiotou, Gökçen Ömeroğlu Simsek, Koen Verbeke, Daniela Xhemalaj, Joanna Domagała-Kulawik","doi":"10.1183/20734735.0192-2023","DOIUrl":"10.1183/20734735.0192-2023","url":null,"abstract":"<p><p>The progress in lung cancer treatment is closely interlinked with the progress in diagnostic methods. There are four steps before commencing lung cancer treatment: estimation of the patient's performance status, assessment of disease stage (tumour, node, metastasis), recognition of histological subtype, and detection of biomarkers. The resection rate in lung cancer is <30% and >70% of patients need systemic therapy, which is individually adjusted. Accurate histological diagnosis is very important and it is the basis of further molecular diagnosis. In many cases only small biopsy samples are available and the rules for their assessment are defined in this review. The use of immunochemistry with at least thyroid transcription factor 1 (TTF1) and p40 is decisive in distinction between lung adenocarcinoma and squamous cell carcinoma. Molecular diagnosis and detection of known driver mutations is necessary for introducing targeted therapy and use of multiplex gene panel assays using next-generation sequencing is recommended. Immunotherapy with checkpoint inhibitors is the second promising method of systemic therapy with best results in tumours with high programmed death-ligand 1 (PD-L1) expression on cancer cells. Finally, the determination of a full tumour pattern will be possible using artificial intelligence in the near future.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信